RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,301,000 | -9.3% | 55,000 | -79.6% | 0.94% | +301.3% |
Q1 2018 | $1,434,000 | +37.4% | 270,000 | +277.6% | 0.23% | +25.1% |
Q3 2017 | $1,044,000 | -85.1% | 71,500 | -80.9% | 0.19% | -90.5% |
Q2 2017 | $7,000,000 | +32.6% | 373,507 | +50.6% | 1.96% | +56.6% |
Q1 2017 | $5,279,000 | -8.0% | 247,956 | -34.4% | 1.25% | -41.4% |
Q4 2016 | $5,740,000 | – | 377,909 | – | 2.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |